Advisory Research Inc Edwards Lifesciences Corp Transaction History

Advisory Research Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $127,408 - $196,911	-2,431 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $32,695 - $37,433	-456 Reduced 15.79%	2,431 $567,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $47,947 - $58,759	-779 Reduced 21.25%	2,887 $635,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $13,210 - $15,265	-237 Reduced 6.07%	3,666 $677,000
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $43,627 - $58,349	-911 Reduced 18.92%	3,903 $747,000
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $5,337 - $6,548	115 Added 2.45%	4,814 $737,000
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $213,099 - $270,593	-4,663 Reduced 49.81%	4,699 $818,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $75,391 - $91,108	-1,776 Reduced 15.95%	9,362 $1.36 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $257,838 - $328,970	6,933 Added 164.88%	11,138 $1.55 Million
Q4 2017 Feb 08, 2018	SELL	$33.79 - $39.39 $71,195 - $82,994	-2,107 Reduced 33.38%	4,205 $474,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $229,062 - $245,094	6,312	6,312 $690,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.